Detected ·
TriGemX Bio
$94M—
Kallyope has rebranded as TriGemX Bio and closed a $94M Series E financing to advance its Phase 3 migraine therapy program.
- Website
- www.kallyope.com
- linkedin.com/company/kallyope
- Amount
- $94 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-10 00:06:22 UTC
- Signal ID
- 8cb8277c-4c15-4ac1-ae61-2f808c4e6050
As the API returns it
{
"id": "8cb8277c-4c15-4ac1-ae61-2f808c4e6050",
"created_at": "2026-10-10T00:06:22.720749Z",
"company_name": "TriGemX Bio",
"company_website_url": "www.kallyope.com",
"company_linkedin_url": "https://www.linkedin.com/company/kallyope",
"event_type": "funding",
"funding_amount": 94000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Kallyope has rebranded as TriGemX Bio and closed a $94M Series E financing to advance its Phase 3 migraine therapy program.*"
}